ASSIGNMENT OF PATENTS AND TRADEMARKS
Exhibit 10.6
ASSIGNMENT OF PATENTS AND TRADEMARKS
WHEREAS, QLT USA, Inc., a Delaware corporation, with offices at 2579 Midpoint Drive, Fort Collins, CO 80525 (ASSIGNOR), owns certain patent applications and/or registrations, as listed in Exhibit A attached hereto and incorporated herein by this reference (PATENTS), and trademarks, including applications and registrations, as listed on Exhibit B attached hereto and incorporated herein by this reference (the MARKS); and
WHREAS, Arius Two, Inc., a Delaware corporation, with offices at 2501 Aerial Center parkway, Suite 205, Morrisville, North Carolina 27560 (ASSIGNEE), desires to acquire all of the right, title and interest in, to and under the PATENTS and to the MARKS in accordance with the terms of that certain Intellectual Property Assignment Agreement dated August 2, 2006 (the Transfer Agreement);
NOW, THEREFORE, in consideration of the sum of One Dollar ($1.00) and other good and valuable consideration paid by ASSIGNEE to ASSIGNOR, the receipt and sufficiency of which hereby is acknowledged, ASSIGNOR does hereby: (1) sell, assign, transfer and convey unto ASSIGNEE all right, title and interest in and to the PATENTS, including all divisions, continuations, continuations-in-part, reexaminations, substitutions, reissues, extensions and renewals of the applications and registrations for the PATENTS (and the right to apply for any of the foregoing); all rights to causes of action and remedies related thereto (including, without limitation, the right to sue for past, present or future infringement, misappropriation or violation of rights related to the foregoing); and any and all other rights and interests arising out of, in connection with or in relation to the PATENTS, and (2) transfer, convey and assign to ASSIGNEE all right, title and interest throughout the world (excluding the United States of America, its territories and possessions (including the Commonwealth of Puerto Rico)) in and to the MARKS, together with all goodwill associated therewith, effective upon ASSIGNORS receipt of all payments due hereunder.
In the event of any conflict or inconsistency between the terms of the Transfer Agreement and the terms hereof, the terms of the Transfer Agreement shall govern.
IN WITNESS WHEREOF, ASSIGNOR has caused this Assignment to be duly executed by an authorized officer on this 2nd day of August, 2006.
By: | /s/ Michael R. Duncan | |
Name: | Michael R. Duncan, President |
EXHIBIT A
COMPANY PATENT RIGHTS
NON-US
Filing Date | Appl. Ser./Pub. Nos. | Country/Status | Title | Priority | ||||
Oct 16 1997 | PCT/US97/18605 WO 1998/17251 (PCT of US 08/734,519)
(334WO1) | PCT completed | Pharmaceutical Carrier Device Suitable for Delivery of Pharmaceutical Compounds to Mucosal Surfaces | US 08/734,519 (Oct. 18, 1996) | ||||
Oct 16, 1997 | AU 97/47574 (Natl stage of PCT/US97/18605)
(334AU1) | AUPN: 729516 Issued: May 17, 2001 Expires: Oct 16, 2017 | Pharmaceutical Carrier Device Mucosal Surfaces | US 08/734,519 (Oct. 18, 1996) | ||||
Apr 26, 2001 | AU 2001/38924 (DIV of AU 97/47574)
(334UA2) | AUPN: 769500 Issued: May 13, 2004 Expires: Oct 16, 2017 | Pharmaceutical Carrier Device Mucosal Surfaces | US 08/734,519 (Oct. 18, 1996) | ||||
Apr 26, 2001 | CA ###-###-#### (Natl stage of PCT/US97/1/18605)
(334CA1) | Canada - pending | Pharmaceutical Carrier Device Mucosal Surfaces | US 08/734,519 (Oct. 18, 1996) | ||||
Apr 26, 1997 | EP97910117.7 (Natl stage of PCT/US97/1/18605)
(334EP1) | EPPN: 0973497 Issued: Dec 11, 2002 Expires: Oct 16, 2017
Also issued in | Pharmaceutical Carrier Device Mucosal Surfaces | US 08/734,519 (Oct. 18, 1996) | ||||
Oct 16, 1997 | JP 10-519467 (Natl stage of PCT/US97/1/18605)
(334EP1) | Japan pending | Pharmaceutical Carrier Device Mucosal Surfaces | US 08/734,519 (Oct. 18, 1996) | ||||
Oct 16, 1997 | JP 200518632 (DIV of JP 10-519467)
Pubn No. 2005-281322 Published Oct 13, 2005 (334JP2) | Japan - pending | Pharmaceutical Carrier Device Mucosal Surfaces | US 08/734,519 (Oct. 18, 1996) |
Filing Date | Appl. Ser./Pub. Nos. | Country/Status | Title | Priority | ||||
Apr 29, 1999 | PCT/US99/09378 WO 99/55312 (PCT of US 09/069,703)
(335WO1) | PCT completed | Pharmaceutical Carrier Device Mucosal Surfaces | US 08/734,519 (Oct 18, 1996) US 09/069,703 (Apr. 29, 1998) | ||||
Apr 29, 1999 | AU 99/39678 (Natl stage of PCT/US99/09378)
(335AU1) | AUPN: 746339 Issued: Aug 1, 2002 Expires: Apr. 29, 2019 | Pharmaceutical Carrier Device Mucosal Surfaces | US 08/734,519 (Oct 18, 1996) US 09/069,703 (Apr. 29, 1998) | ||||
Apr 29, 1999 | CA 2,329,128 (Natl stage of PCT/US99/09378)
(335CA1) | Canada pending | Pharmaceutical Carrier Device Mucosal Surfaces | US 08/734,519 (Oct 18, 1996) US 09/069,703 (Apr. 29, 1998) | ||||
Apr 29, 1999 | EP 99922753.1 (Natl stage of PCT/US99/09378)
(335EP1) | EP 1079813 Issued: Feb 9, 2005 Expires: Apr. 29, 2019
Also issued in | Pharmaceutical Carrier Device Mucosal Surfaces | US 08/734,519 (Oct 18, 1996) US 09/069,703 (Apr. 29, 1998) | ||||
Apr 29, 1999 | JP 2000545511 (Natl stage of PCT/US99/09378)
(335JP1) | Japan pending | Pharmaceutical Carrier Device Mucosal Surfaces | US 08/734,519 (Oct 18, 1996) US 09/069,703 (Apr. 29, 1998) | ||||
Apr 29, 1999 | JP ###-###-#### (DIV of JP 2000545511)
(335JP2) | Japan pending | Pharmaceutical Carrier Device Mucosal Surfaces | US 08/734,519 (Oct 18, 1996) US 09/069,703 (Apr. 29, 1998) |
Filing Date | Appl. Ser./Pub. Nos. | Country/Status | Title | Priority | ||||
Apr 11, 2003 | PCT/US 03/11313 WO 03/086345 (PCT of US 10/121,430)
(237WO1) | PCT completed | Process for Loading a Drug Delivery Device | US 10/121,430 (Apr. 11, 2002) | ||||
Aug 16, 2004 | PCT/US2004/026531 WO 2005/016321 (PCT of US 60/495,356)
(309WO1) | PCT completed | Adhesive Bioerodible Transmucosal Drug Delivery System | US 60/495,356 (Aug 15, 2003) | ||||
Aug 16, 2004 | AU 2004/264974 (Natl stage of PCT/US2004/026531)
(309AU1) | Australia - pending | Adhesive Bioerodible Transmucosal Drug Delivery System | US 60/495,356 (Aug 15, 2003) | ||||
Aug 16, 2004 | CA 2,535,846 (Natl stage of PCT/US2004/026531)
(309CA1) | Canada - pending | Adhesive Bioerodible Transmucosal Drug Delivery System | US 60/495,356 (Aug 15, 2003) | ||||
Aug 16, 2004 | EP 04781250.8 (Natl stage of PCT/US2004/026531) Publ EP1660056 Published May 31, 2006
(309EP1) | EP - pending | Adhesive Bioerodible Transmucosal Drug Delivery System | US 60/495,356 (Aug 15, 2003) | ||||
Aug 16, 2004 | JP (Natl stage of PCT/US2004/026531)
(309JP1) | JP - pending | Adhesive Bioerodible Transmucosal Drug Delivery System | US 60/495,356 (Aug 15, 2003) | ||||
Aug 16, 2004 | MX PA/a/2006/001776 (Natl stage of PCT/US2004/026531)
(309MX1) | MX - pending | Adhesive Bioerodible Transmucosal Drug Delivery System | US 60/495,356 (Aug 15, 2003) |
SCHEDULE 1.22
COMPANY TRADEMARK RIGHTS
BEMA
Country | Application No. / Filed Date | Registration No. / Registration | Expiry /Renewal Date | Description/Comments | Priority | |||||
Australia | 1028272 Nov 4, 2004 | 1028272 Apr 11, 2005 | Nov 4, 2014 Nov 4, 2014 | Cl. 05 - Polymer Film, namely, adhesive bandages for topical application of pharmaceuticals; Cl. 10 - Polymer film for use as an applicator for pharmaceuticals | US 78/424675 May 25, 2004 | |||||
Japan | 2004-107883 Nov 25, 2004 | pending | CL 05, CL 10 - Polymer film, namely, adhesive bandages for topical application of pharmaceuticals | US 78/424675 May 25, 2004 | ||||||
European Community OHIM | 004097416 Nov 4, 2004 | pending | Cl. 05 - Polymer Film, namely, adhesive bandages for topical application of pharmaceuticals; Cl. 10 - Polymer film for use as an applicator for pharmaceuticals | US 78/424675 May 25, 2004 |